[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@EisaiGlobalOnc Avatar @EisaiGlobalOnc Eisai Oncology Medical

Eisai Oncology Medical posts on X about $4523t, drugs, topics, liver the most. They currently have XXXXX followers and XX posts still getting attention that total X engagements in the last XX hours.

Engagements: X #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #

Social topic influence $4523t 12.5%, drugs 2.27%, topics 1.14%, liver 1.14%, health care 1.14%, mbc XXXX%

Top accounts mentioned or mentioned by @asco @rnemd @drhelenmackay @jgong15 @maychomd @dsmgyo @pamsolimanmd @icmlugano @fbackesmd @jghanekar1993

Top Social Posts #

Top posts by engagements in the last XX hours

"The 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer are now available. Differentiated thyroid cancer is the most prevalent type of thyroid cancer and among the most frequently diagnosed cancers in the US"
X Link @EisaiGlobalOnc 2025-10-02T13:00Z 1344 followers, XX engagements

"I think there has possibly been the biggest paradigmatic shift that weve seen in the treatment of endometrial cancer. Watch @DrHelenMacKay explain the importance of the TME in gynecologic tumors and related topics in a new video"
X Link @EisaiGlobalOnc 2025-09-30T13:00Z 1344 followers, XX engagements

"With 750000 deaths and an estimated 865000 new cases worldwide in 2022 liver cancer is the third leading cause of cancer death and the sixth most frequently diagnosed. Eisai is dedicated to raising awareness and advancing solutions for those living with cancer"
X Link @EisaiGlobalOnc 2025-10-10T13:00Z 1344 followers, XX engagements

"On Breast Cancer Awareness Day and every day Eisai is dedicated to offering helpful resources including our Magnolia program which provides at-home meals service animals and more for those living with cancer and the loved ones who care for them"
X Link @EisaiGlobalOnc 2025-10-13T13:00Z 1344 followers, XX engagements

"Our dose optimization study is still recruiting with @rne_md as an investigator. The objective of this study is dose optimization of E7386 in combination with other anticancer drug(s) in patients with endometrial carcinoma"
X Link @EisaiGlobalOnc 2025-09-22T13:00Z 1344 followers, XXX engagements

"Enrollment is open: @rne_md is one of the investigators in a study to determine the optimal dose of E7386 in combination with other anticancer drug(s) in patients with endometrial carcinoma (EC). #oncology #EC"
X Link @EisaiGlobalOnc 2025-09-25T13:00Z 1344 followers, XXX engagements

"Join us at #ESMO25 to explore new updates in #cancer treatment research"
X Link @EisaiGlobalOnc 2025-10-03T14:38Z 1343 followers, XXX engagements

"Our team recently attended the annual meeting of the Japanese Association for Molecular Targeted Therapy of Cancer in early July. We were honored to meet with our fellow attendees and share new research"
X Link @EisaiGlobalOnc 2025-10-03T13:39Z 1343 followers, XXX engagements

"According to recent data about 170000 women in the US are living with metastatic breast cancer. In observance of Breast Cancer Awareness Month Eisai continues to focus our human health care (hhc) mission on exploring treatment options and supporting people living with cancer"
X Link @EisaiGlobalOnc 2025-10-08T14:00Z 1344 followers, 85.6K engagements

"Our team is honored to attend the European Society for Medical Oncology (ESMO) Congress in Berlin and share our latest research on endometrial cancer. We look forward to seeing you next week"
X Link @EisaiGlobalOnc 2025-10-09T13:00Z 1344 followers, XX engagements

"What are some of the unmet needs in metastatic breast cancer (mBC) Learn more from the experts in our video below"
X Link @EisaiGlobalOnc 2025-10-08T13:00Z 1344 followers, XX engagements